What amount sold does PharmaCyte Biotech, Inc. report in Form D filings?

The latest linked filings report $79.2M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was PharmaCyte Biotech, Inc.'s most recent SEC filing?

PharmaCyte Biotech, Inc.'s most recent Form D filing was on 2025-09-04.

How many investors does PharmaCyte Biotech, Inc. have?

The most recent Form D filing lists 12 investor(s).

What type of securities does PharmaCyte Biotech, Inc. offer?

PharmaCyte Biotech, Inc.'s SEC Form D filings indicate equity offerings.

PharmaCyte Biotech, Inc.

CIK: 0001157075·Biotechnology·LAS VEGAS, NV·Corporation

Reported Sold

$79,156,000

Total Filings

Identified Offerings

Last Filed

Sep 4, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 4, 2025Form D — New notice

Reported sold: $7,000,000 · Target: $7,000,000

Rule 506(b)·12 investors

Sep 1, 2021Form D — New notice

Reported sold: $70,000,000 · Target: $70,000,000

Rule 506(b)·19 investors

Jan 19, 2016Form D — New notice

Reported sold: $1,020,000 · Target: $3,060,000

Rule 506(b)·2 investors

Dec 27, 2013Form D — New notice

Reported sold: $1,136,000 · Target: $3,500,000

Rule 506(b)·21 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$5,840,000

Amendment Rate

Latest reported sold across 4 identified offerings

$79,156,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kenneth L. Waggoner

Related Person

Appears on 2 filings

Gerald W. Crabtree

Related Person

Appears on 2 filings

Michael M. Abecassis

Related Person

Appears on 1 filing

Walker R. Wayne

Related Person

Appears on 1 filing

Jonathan L. Schechter

Related Person

Appears on 1 filing

Patricia Gruden

Related Person

Appears on 1 filing

Robert Weinstein

Related Person

Appears on 1 filing

Carlos Trujillo

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 4, 2025	New	$7,000,000	$7,000,000	12
Sep 1, 2021	New	$70,000,000	$70,000,000	19
Jan 19, 2016	New	$3,060,000	$1,020,000	2
Dec 27, 2013	New	$3,500,000	$1,136,000	21

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026